Related Experiment Video
Updated: Jun 7, 2026

Polysome Profiling in Leishmania, Human Cells and Mouse Testis
Published on: April 8, 2018
New insights into 5q- syndrome as a ribosomopathy
Jillian L Barlow1, Lesley F Drynan, Nicola L Trim
1MRC Laboratory of Molecular Biology, Cambridge, UK.
Abstract:
Myelodysplastic Syndromes (MDS) are a heterogeneous group of acquired clonal bone marrow disorders, characterised by ineffective hematopoiesis. The mechanisms underlying many of these blood disorders have remained elusive due to the difficulty in pinpointing specific gene mutations or haplo-insufficencies, which can occur within large deleted regions. However, there is an increasing interest in the classification of some of these diseases as ribosomopathies. Indeed, studies have implicated Ribosomal Protein (RP) S14 as a strong candidate for haploinsufficiency in 5q- syndrome, a particular form of MDS. Recently, two novel mouse models have provided evidence for the involvement of both RPS14 and the p53 pathway, and specific miRNAs in 5q- syndrome. In this review we will discuss: 5q- syndrome mouse models, the possible mechanisms underlying this blood disorder with respect to the candidate genes and comparisons with other ribosomopathies and the involvement of the p53 pathway in these diseases.
Insights
Myelodysplastic Syndromes (MDS) are bone marrow disorders. New mouse models suggest Ribosomal Protein S14 (RPS14) haploinsufficiency and p53 pathway involvement are key in 5q- syndrome, a type of MDS.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Myelodysplastic Syndromes (MDS) are clonal bone marrow disorders with ineffective hematopoiesis.
- Mechanisms are often unclear due to large deleted regions and gene mutations.
- An increasing number of MDS cases are being classified as ribosomopathies.
Purpose of the Study:
- To review novel mouse models of 5q- syndrome.
- To discuss the role of Ribosomal Protein S14 (RPS14) haploinsufficiency in 5q- syndrome.
- To explore the involvement of the p53 pathway and microRNAs in this condition.
Main Methods:
- Review of recent literature on 5q- syndrome mouse models.
- Analysis of genetic and molecular mechanisms in MDS.
- Comparative study of ribosomopathies.
Main Results:
- Two novel mouse models provide evidence for RPS14 involvement in 5q- syndrome.
- The p53 pathway and specific miRNAs are implicated in the pathogenesis.
- RPS14 haploinsufficiency is a strong candidate mechanism for 5q- syndrome.
Conclusions:
- 5q- syndrome mouse models offer insights into MDS pathogenesis.
- RPS14 haploinsufficiency and p53 pathway activation are critical.
- Understanding these mechanisms may lead to new therapeutic strategies for MDS and related ribosomopathies.
More Related Videos
Related Concept Videos
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
The Nucleolus
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

